Average Co-Inventor Count = 4.53
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Acadia Pharmaceuticals Inc. (18 from 92 patents)
2. Verenium Corporation (1 from 69 patents)
3. Acadia Pharmacueticals Inc. (1 from 1 patent)
20 patents:
1. 10525046 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
2. 10028944 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
3. 9566271 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
4. 9211289 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
5. 8921393 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
6. 8906663 - Nitrilases
7. 8618130 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
8. 8377959 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
9. 8227487 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
10. 8008323 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
11. 7994193 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
12. 7875632 - Selective serotonin receptor inverse agonists as therapeutics for disease
13. 7863296 - Selective serotonin receptor inverse agonists as therapeutics for disease
14. 7820695 - Selective serotonin receptor inverse agonists as therapeutics for disease
15. 7732462 - Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases